首页> 外文期刊>PLoS One >Characteristics and Outcomes among Older HIV-Positive Adults Enrolled in HIV Programs in Four Sub-Saharan African Countries
【24h】

Characteristics and Outcomes among Older HIV-Positive Adults Enrolled in HIV Programs in Four Sub-Saharan African Countries

机译:四个撒哈拉以南非洲国家的艾滋病毒/艾滋病毒阳性项目的年龄特征和结果

获取原文
           

摘要

Background Limited information exists on adults ≥50 years receiving HIV care in sub-Saharan Africa. Methodology Using routinely-collected longitudinal patient-level data among 391,111 adults ≥15 years enrolling in HIV care from January 2005–December 2010 and 184,689 initiating ART, we compared characteristics and outcomes between older (≥50 years) and younger adults at 199 clinics in Kenya, Mozambique, Rwanda, and Tanzania. We calculated proportions over time of newly enrolled and active adults receiving HIV care and initiating ART who were ≥50 years; cumulative incidence of loss to follow-up (LTF) and recorded death one year after enrollment and ART initiation, and CD4+ response following ART initiation. Findings From 2005–2010, the percentage of adults ≥50 years newly enrolled in HIV care remained stable at 10%, while the percentage of adults ≥50 years newly initiating ART (10% [2005]-12% [2010]), active in follow-up (10% [2005]-14% (2010]), and active on ART (10% [2005]-16% [2010]) significantly increased. One year after enrollment, older patients had significantly lower incidence of LTF (33.1% vs. 32.6%[40–49 years], 40.5%[25–39 years], and 56.3%[15–24 years]; p-value0.0001), but significantly higher incidence of recorded death (6.0% vs. 5.0% [40–49 years], 4.1% [25–39 years], and 2.8% [15–24 years]; p-valve0.0001). LTF was lower after vs. before ART initiation for all ages, with older adults experiencing less LTF than younger adults. Among 85,763 ART patients with baseline and follow-up CD4+ counts, adjusted average 12-month CD4+ response for older adults was 20.6 cells/mm3 lower than for adults 25–39 years of age (95% CI: 17.1–24.1). Conclusions The proportion of patients who are ≥50 years has increased over time and been driven by aging of the existing patient population. Older patients experienced less LTF, higher recorded mortality and less robust CD4+ response after ART initiation. Increased programmatic attention on older adults receiving HIV care in sub-Saharan Africa is warranted.
机译:背景信息在撒哈拉以南非洲,接受HIV护理的50岁以上成年人的信息有限。方法使用2005年1月至2010年12月从391,111名≥15岁的HIV登记成人和184,689名发起ART的常规患者中收集的纵向患者水平数据,我们比较了美国199所诊所中年龄较大(≥50岁)和年轻人之间的特征和结果。肯尼亚,莫桑比克,卢旺达和坦桑尼亚。我们计算了接受艾滋病毒治疗并开始接受抗逆转录病毒治疗且≥50岁的新入职和活跃成年人的时间比例;入组和抗逆转录病毒治疗后一年的随访损失累积累积率(LTF),并记录死亡,抗逆转录病毒治疗后CD4 +反应。调查结果从2005年至2010年,刚参加HIV护理的50岁以上成年人的百分比稳定在10%,而刚开始抗病毒治疗的50岁以上成年人的百分比(10%[2005] -12%[2010])活跃随访(10%[2005] -14%(2010))和抗病毒治疗(10%[2005] -16%[2010])活跃度增加,入组一年后,老年患者的发生率显着降低。 LTF(33.1%vs. 32.6%[40-49岁],40.5%[25-39岁]和56.3%[15-24岁]; p值<0.0001),但记录的死亡发生率明显更高(6.0 %vs. 5.0%[40-49岁],4.1%[25-39岁]和2.8%[15-24岁]; p阀<0.0001)。在85,763名基线和随访CD4 +计数的ART患者中,调整后的老年人平均12个月CD4 +应答比25-39岁的成年人低20.6个细胞/ mm3( 95%CI:17.2–24.1)。结论e≥50岁随着时间的推移而增加,并且是由现有患者群体的老龄化驱动的。年龄较大的患者在接受ART治疗后经历的LTF减少,记录的死亡率更高,CD4 +反应减弱。在撒哈拉以南非洲地区,有计划的重视对接受艾滋病毒治疗的老年人的重视。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号